Play
A Good Life
After his treatment for prostate cancer led to ED, Cliff felt “devastated” and like he’d failed. Finding a solution brought back “the intimacy – and then some” – that he and his wife, Marilyn, had lost.
Hard: The Fight to Solve ED
Experiencing ED can be frustrating and confusing, but it doesn’t have to be. See how these men found a path to feeling whole again in this video series.
Play
Play
Reborn
"It was like being reborn.” Andy had been living with ED and diabetes for years; other ED treatments had failed. Then, Dr. Abram McBride opened his eyes to an option to achieve satisfaction and restore intimacy.
Play
Restoring Robert
For Robert, finding a solution that allowed him to be independent and spontaneous was “the best thing I ever did in my life.” His urologist, Dr. Singh, says men who receive a penile implant are “probably the happiest patients that I have.”
Play
No Regrets
Lawrence had ED for years and battled feelings of isolation. After he confided in his urologist and found treatment, he “felt proud” and only wished he’d done it sooner.
Play
Desperate for a Cure
When Richard started experiencing ED, he hid it from his wife, Maria, by using pills. But when the pills stopped working, he finally opened up to her and together they found a solution.
Dr. Samantha Nealon
The host of this video series, Dr. Nealon, is a urologist who’s dedicated her career to understanding ED and helping patients get the care they need.
ED might feel embarrassing, but it’s actually quite common. In fact, it is estimated that 322 million men worldwide will be affected by ED by 20251
Boston Scientific is committed to overcoming the stigma and restoring hope by speaking candidly about what men with ED are feeling – physically and emotionally.
We know ED isn’t just about intimacy. Many men with ED can suffer from depression and experience anger.2 Our HARD: The Fight to Solve ED video series is just one step we’re taking to help men and their partners. We’re also spreading knowledge and hope through ongoing patient outreach and education. Did you know that after receiving treatment for ED, men had lower rates of depression?3
Explore EDCure.org to learn more.
25%–75% of men who have a nerve-sparing radical prostatectomy to treat prostate cancer experience ED afterward4
- Aytac IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84:50–56.
- Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151:54–61.
- Nackeeran S, Havanur A, Ory J, Althof S, Ramasamy R. Erectile dysfunction is a modifiable risk factor for major depressive disorder: analysis of a Federated Research Network. J Sex Med. 2021;18:2005–2011.
- Matthew AG, Goldman A, Trachtenberg J, et al. Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress. J Urol. 2005;174:2105–2110.
Important Safety Information for Patients Considering an Implant
AMS 700™ Inflatable Penile Implant
Caution: U.S. federal law restricts this device to sale by or on the order of a physician.
Your doctor is your best source for information on the risks and benefits of the AMS 700™ Inflatable Penile Prosthesis. Talk to your doctor for a complete listing of risks, warnings and important safety information.
The AMS 700™ Inflatable Penile Prosthesis is intended for use in the treatment of male erectile dysfunction (impotence). Implanting a penile prosthesis will damage or destroy any remaining ability to have a natural erection, as well as make other treatment options (oral medications, vacuum devices or injections) impossible.
Men with diabetes, spinal cord injuries or skin infections may have an increased risk of infection. Implantation may result in penile curvature or scarring. Some AMS 700 devices contain an antibiotic (InhibiZone™ Antibiotic Surface Treatment). The device is not suitable for patients who are allergic to the antibiotics contained within the device (rifampin, minocycline or other tetracyclines) or those who have systemic lupus; these patients should use one of the devices that do not contain InhibiZone Antibiotic Surface Treatment.
Potential risks may include: device malfunction/failure leading to additional surgery, device migration potentially leading to exposure through the tissue, wearing away/loss of tissue (device/tissue erosion), infection, unintended inflation of the device and pain/soreness. MH-545411-AB
Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.
This material is for informational purposes only and not meant for medical diagnosis. This information does not constitute medical or legal advice, and Boston Scientific makes no representation regarding the medical benefits included in this information. Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health.
The physicians featured in these videos are consultants of Boston Scientific.
The patients featured in these videos were compensated for their travel and/or time.
All images are the property of Boston Scientific.
All trademarks are the property of their respective owners.
©2023 Boston Scientific Corporation. All rights reserved.
MH-1265605-AH JUL 2023